Livacol^TM

Indication:
Livacol^TM is indicated for the treatment of
• Primary Biliary Cholangitis (PBC) in combination with Ursodeoxycholic Acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA
• Cholestatic liver disease
• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Dosage & Administration:
Starting Dosage: The recommended starting dosage of Obeticholic Acid is 5 mg orally once daily.
Dosage Titration: If an adequate reduction in alkaline phosphatase (ALP) and/or total bilirubin has not been achieved after 3 months of Obeticholic Acid 5 mg once daily and the patient is tolerating Obeticholic Acid, increase the dosage of Obeticholic Acid to 10 mg once daily.
Maximum Dosage: The maximum recommended dosage of Obeticholic Acid is 10 mg once daily.

Preparation:
Livacol^TM 5: Each box contains 20 tablets in blister pack.
Livacol^TM 10: Each box contains 10 tablets in blister pack.